Osteoporosis and metabolic bone disease

Bone Pathology

Volumn , Issue , 2009, Pages 217-237

  Khurana, Jasvir S ^a   Fitzpatrick, Lorraine A ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Albers Schonberg marble bone disease; Amyloidosis; Biliary rickets; Calcitonin; Crystallysis; DEXA scan; Enteric rickets; Gastric rickets; Gaucher disease; Glucocerebrosidase; Glycosaminoglycanosis; Hypercalcemia; Hypercalciuria; Hyperparathyroidism; Hyperphosphaturia; Hyperreflexia; Hypocalcemia; Hypophosphatemia; Metabolic bone diseas; Mucopolysacharidoses; Osteogenesis imperfecta; Osteomalacia; Osteopetrosis; Osteoporosis; Paget disease; Parathyroid hormone; Phosphatonin; Rachitism; Renal osteodystrophy; Scurvy; Serum alkaline phosphatase; Vitamin D

Indexed keywords

EID: 84878678863     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-347-9_14     Document Type: Chapter

References (36)

1. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxylterminal ligands. Endo Rev 26:78-113, 2005.
2. Bringhurst FR, Stern AM, Yotts, M, Mizrahi N, Segre GV, Potts JT, Jr. Peripheral metabolism of PTH: Fate of biologically active amino terminus in vivo. Am J Physiol 255:E886-E893, 1988.
3. Friedman PA, Goodman, WG. PTH (1-84/PTH (7-84): A balance of power. Am J Physiol Renal Physiol 290:F975-F084, 2006.
4. Liu S, Gupta A, Quarles LD. Emerging role of fibroblast growth factor 23 and in a bone-kidney axis regulating phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329-335, 2007.
5. Imel EA, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev 4:434-439, 2007.
6. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650, 1993
7. Raisz L. Pathogenesis of osteoporosis: Concepts, conflicts and prospects. J Clin Invest 115:3318-3325, 2005.
8. Rosen CJ. Postmenopausal osteoporosis. N Engl J Med 353:595-603, 2005.
9. WHO Technical Report Series 921 Prevention and management of osteoporosis, 2000.
10. Giguere Y, Rousseau F. The genetics of osteoporosis: Complexities and difficulties. Clin Genet 57:161-169, 2000.
11. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 367:284-216, 1994.
12. Uitterlinden AG, et al. Relation of alleles of the collagen type I-alpha-1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016-1021, 1998.
13. Mankin HJ. Rickets, osteomalacia and renal osteodystrophy Part I. J Bone Joint Surg 56-A(1):101-128, 1974.
14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373, 2006.
15. Bielesz B. Emerging role of a phosphatonin in mineral homeostasis and its derangements. Eur J Clin Invest 36(Suppl 2):34-42, 2006.
16. Hochberg Z. Vitamin-D-dependent rickets type 2. Hormone Res 58:297-302, 2002.
17. Collins MT. Spectrum and national history of fibrous dysplasia of bone. J Bone Miner Res 21(Suppl 2):P99-P104, 2006.
18. Riminucci M, Gehron Robey P, Biano P. The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev 4:401-411, 2007.
19. Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 5:S3-S15, 2004.
20. Chavassieux P, Seeman E, Delmas PD. Insights into material and structural basis of bone fragility from diseases associated with fractures: How determinants of the biochemical properties of bone are compromised by disease. Endo Rev 28:151-164, 2007.
21. Gal-Moscovici A, Sprague SM. Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 14(1):27-36, 2007.
22. Hruska KA, Saab G, Mathew S, Lund R. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 20(4):309-15, 2007.
23. Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab 2:494-503, 2005.
24. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001-3005, 2007.
25. Layfield R, Shaw B. Ubiquitin-mediated signaling and Paget's disease of bone. BMC Biochem 8(Suppl 1):1-7, 2007.
26. Siris ES, Roodman GD. Paget's Disease of Bone. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 6th edition. Edited by M. J. Favus. American Society for Bone and Mineral Research, Washington, D. C. pp. 320-330, 2006.
27. Picken MM. New insights into systemic amyloidosis: The importance of diagnosis of specific type. Curr. Opin. Nephrol. Hypertens. 16:196-203, 2007.
28. Comenzo RL. Current and emerging views and treatment of systemic light-chain (AL) amyloidosis. Contrib Nephrol 153:195-210, 2007.
29. Whyte MP, Chines A, Silva DP, Landt Y, Ladenson JH. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetrosis among the sclerosing bone disorders. J Bone Miner Res 11:1438-1443, 1996.
30. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 351:2839-2849, 2004.
31. Brockstedt H, Bollerslev J, Melsen F, Mosekilde L. Cortical bone remodeling in autosomal dominant osteopetrosis: A study of two different phenotypes. Bone 18:67-72, 1996.
32. Marini J. Osteoporosis Imperfecta. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 6th edition edited by M. J. Favus. American Society for Bone and Mineral Research, Washington, D. C. pp. 418-421, 2006.
33. Jaffe HL. Osteogenesis Imperfecta. In: Metabolic, Degenerative and Inflammatory Diseases of Bones and Joints. Lea Febige, Philadelphia, 1972.
34. Muenzer J. The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations. J Pediatr 144:S27-S34, 2004.
35. Vellodi A. Lysosomal storage disorders. Br J Haematol 128:413-431, 2004.
36. Rimoin DL, Silberberg R, Hollister DW. Chondro-osseous pathology in the chondrodystrophies. Clin Orthop 114:137-152, 1976.